Cita APA

Lekmine, S., Benslama, O., Kadi, K., Martín García, A. I., Shamsul Ola, M., Abdullah Yilmaz, M., & Ali, A. (2024). Therapeutic potential of Hyoscyamus niger-derived compounds: Targeting ovarian cancer through antioxidant activity and EGFR tyrosine kinase inhibition.

Citación estilo Chicago

Lekmine, S., O. Benslama, K. Kadi, A. Ignacio Martín García, M. Shamsul Ola, M. Abdullah Yilmaz, y A. Ali. Therapeutic Potential of Hyoscyamus Niger-derived Compounds: Targeting Ovarian Cancer Through Antioxidant Activity and EGFR Tyrosine Kinase Inhibition. 2024.

Cita MLA

Lekmine, S., et al. Therapeutic Potential of Hyoscyamus Niger-derived Compounds: Targeting Ovarian Cancer Through Antioxidant Activity and EGFR Tyrosine Kinase Inhibition. 2024.